GPI 1485

DRUG3 trials

Sponsors

University of Rochester, Eisai Inc.

Conditions

ImpotenceParkinson DiseaseParkinson's DiseaseProstate Cancer

Phase 2

NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485

CompletedNCT00076492

University of RochesterParkinson Disease

Start: 2004-01-31End: 2005-09-30Target: 195Updated: 2012-11-02

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

CompletedNCT00090376

Eisai Inc.Impotence, Prostate Cancer

Start: 2003-12-31Target: 240Updated: 2008-11-07

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

CompletedNCT00209508

Eisai Inc.Parkinson's Disease

Start: 2002-11-30End: 2005-10-31Target: 200Updated: 2008-11-07

Related Papers

Measuring Disease Progression in Early Parkinson Disease

JAMA Neurology2014-04-0785 citations